Exelixis (EXEL) Short term Debt (2010 - 2017)
Exelixis (EXEL) posted quarterly Short term Debt of $113.3 million for Q1 2017, up 312.18% year-over-year from $27.5 million in Q1 2016, and up 3.87% quarter-over-quarter from $109.1 million in Q4 2016.
Analysis
Exelixis (EXEL) Short term Debt (2010 - 2017) Analysis & Trends
Exelixis' Short term Debt history runs 8 years deep, the most recent figure standing at $113.3 million for Q1 2017.
- In Q1 2017, Short term Debt rose 312.18% year-over-year to $113.3 million; the TTM figure through Mar 2017 stood at $113.3 million (up 312.18% YoY), while the FY2016 annual figure was $109.1 million, changed N/A from the prior year.
- Short term Debt for Q1 2017 stood at $113.3 million, up from $109.1 million in the prior quarter.
- The five-year high for Short term Debt was $113.3 million in Q1 2017, with the low at $450000.0 in Q3 2015.
- The 5-year median for Short term Debt is $27.5 million (2016), against an average of $45.7 million.
- The sharpest annual moves came in 2015 and 2016: Short term Debt tumbled 99.53% in 2015, then surged 6425.56% in 2016.
- Exelixis' Short term Debt stood at $10.0 million in 2013, then soared by 874.49% to $97.4 million in 2014, then slumped by 99.54% to $450000.0 in 2015, then soared by 24149.33% to $109.1 million in 2016, then climbed by 3.87% to $113.3 million in 2017.
- Business Quant data shows EXEL's Short term Debt at $113.3 million in Q1 2017, $109.1 million in Q4 2016, and $29.4 million in Q3 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Exelixis | 14.81 Bn | 13.97 Bn | 608.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | 113.35 Mn |
| Dec 30, 2016 | 109.12 Mn |
| Sep 30, 2016 | 29.37 Mn |
| Jun 30, 2016 | 27.50 Mn |
| Mar 31, 2016 | 27.50 Mn |
| Sep 30, 2015 | 450,000.00 |
| Mar 31, 2015 | 3.91 Mn |
| Dec 31, 2014 | 97.45 Mn |
| Sep 30, 2014 | 96.50 Mn |
| Jun 30, 2014 | 94.21 Mn |
| Dec 31, 2013 | 10.00 Mn |
| Sep 30, 2013 | 10.00 Mn |
| Jun 30, 2013 | 10.00 Mn |
| Mar 31, 2013 | 10.00 Mn |
| Dec 31, 2012 | 10.00 Mn |
| Sep 30, 2012 | 10.00 Mn |
| Jun 30, 2012 | 10.00 Mn |
| Mar 31, 2012 | 10.00 Mn |
| Sep 30, 2011 | 28.90 Mn |
| Jun 30, 2011 | 28.90 Mn |